Human cardiomyocytes for drug discovery
Introduction: Cardiac drug discovery are based in old methods that use animals, animal cells or modified cells that do not faithfully represent human cardiac phenotypes. Objective: Here, we aimed to show that cardiomyocytes derived from human iPS cells represent a new tool for cardiac drug discovery...
Saved in:
Main Authors: | Diogo Gonçalves Biagi (Author), Jéssica Gonçalves (Author), Estela Cruvinel (Author), Renata Damiani (Author), Flavia Valgode (Author), Fabiana Medeiros (Author), Camila G Moreira (Author), Evelyn Santos (Author), Rodrigo Marcon (Author), Calixto João (Author), Gabriela Venturini (Author), Alexandre Pereira (Author), Éden Ferreira (Author), Renato Mortara (Author), Marcos C Valadares (Author) |
---|---|
Format: | Book |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ),
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi, et al.
Published: (2018) -
Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi, et al.
Published: (2018) -
Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi, et al.
Published: (2018) -
A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Diogo Crispim Nascimento Portella, et al.
Published: (2021) -
Visions of Cardiomyocyte Fundamental Concepts of Heart Life and Disease
Published: (2020)